Ribociclib for HR-Positive, Advanced Breast Cancer

N Engl J Med. 2017 Jan 19;376(3):288-289. doi: 10.1056/NEJMc1615255.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Breast Neoplasms*
  • Breast*
  • Humans
  • Receptor, ErbB-2
  • Receptors, Estrogen

Substances

  • Receptors, Estrogen
  • Receptor, ErbB-2